MFMaíra Peres Ferreira

Maíra Peres Ferreira

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Maíra Peres Ferreira has a total of 80 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    PHOTOPROTECTIVE EFFICACY OF ROBUSTA GREEN COFFEE (Coffea canephora) EXTRACT AND LINSEED (Linum usitatissimum) OIL-BASED NANOEMULSIONS AGAINST UVB-INDUCED DAMAGE TO THE SKIN

    by Claudia Tiemi Nakano, Clara Ruiz de Souza, Letícia Falcai Ferrante, Maíra Peres Ferreira Duarte, Camila Cubayachi, Fabiana Testa Moura de Carvalho Vicentini, Renê Oliveira Do Couto, Daniela Cristina de Medeiros, Marcela Maria Baracat, Waldiceu Aparecido Verri Jr., et al.

    This study adopted a preclinical model to develop and evaluate the photoprotective efficacy of nanoemulsions (NEs) containing Robusta green coffee extract (GCE) and linseed oil (LO) against UVB-induced skin damage. The GCE, rich in polyphenols and caffeine, demonstrated antioxidant activity in vitro. The LO met quality standards based on physicochemical analyses (peroxide, acid, and saponification values), confirming its suitability for formulation. Using Chremophor® RH 40 and Span® 80 as surfactants yielded stable and nanometric NEs, since both the control with only LO (NE-C) and the NEs loaded with GCE at concentrations of 0.25% (NE-0.25), 0.5% (NE-0.5), and 1.0% (NE-1.0) showed D50 < 90 nm, PDI ≤ 0.2, and ZP < -26.0 mV. Morphological studies confirmed a spherical shape and uniform droplet distribution, with no aggregation. Moreover, all NEs presented a pH of around 5, compatible with human skin. The NEs were topically applied to the dorsal skin of hairless mice before and after UVB exposure. Besides being well tolerated following an acute irritation test, NE-0.25 markedly reduced neutrophil migration (49%) while recovering the skin antioxidant capacity (catalase activity and reduced glutathione levels) to near-baseline values within 12 h of UVB exposure, thus highlighting its potential as a skin anti-aging strategy.

  • Production of apoferritin/chitosan complex by Maillard reaction as a promising platform to enhance pDNA delivery

    by Natália F. Paiva, Isabella K. Demonari, Isabela P. Domingos, Amanda M. Gimenez, Marcia Bertoz, Wendy M. Rios, Maíra P.F. Duarte, Rose Mary Zumstein Georgetto Naal, Osvaldo de Freitas, Fabiana Testa Moura de Carvalho Vicentini


  • Ferritin-Based Systems as a Platform for DNA Construct Delivery: Preparation, Characterization, and In Vitro Evaluation

    by Natália F. Paiva, Wendy M. Rios, Gabriel Pocci Antonio, Gisele M. Umino, Maíra Peres Ferreira, Izaíra Tincani Brandão, José Orestes Del Ciampo, Maria Vitória Lopes Badra Bentley, Rúbia Casagrande, Waldiceu A. Verri, et al.


  • Self-assembled nanovaccine based on apoferritin: Development and vaccine regimen evaluation

    by Camila Machado França de Almeida, Wendy Martin Rios, Maíra Peres Ferreira Duarte, Izaíra Tincani Brandão, Natalia Floriano Paiva, Fabiana Testa Moura de Carvalho Vicentini


  • Open Access

    Assessing α-Bisabolol as a Transmucosal Permeation Enhancer of Buccal Local Anesthetics

    by Renê Oliveira Do Couto, Douglas Vieira Thomaz, Maira Perez Ferreira Duarte, Renata Fonseca Vianna Lopez, Vinícius Pedrazzi, Osvaldo de Freitas, Gianluca Martino Tartaglia

    Needle-free buccal anesthesia improves dental treatment outcomes for both patients and dentists. In this study, we report on an assessment of the enhancement effects of α-bisabolol on the in vitro transmucosal permeation of prilocaine hydrochloride (PCl) and lidocaine hydrochloride (LCl) from needleless buccal films. We also evaluated the mechanical properties of the film, which consisted of Methocel™ K100 LV as the film-forming polymer (3% m·m−1), PEG 400 as a cosolvent (15% m·m−1 based on drug loading), α-bisabolol (15 and 30% m·m−1 based on drug loading), and the drugs combined at a 1:1 ratio (15 mg·unit−1). The porcine esophageal epithelium was used as a membrane barrier, and artificial saliva was the release medium. After a 1 h experiment at 25 ± 2 °C, α-bisabolol significantly decreased, rather than enhanced, the permeation fluxes (five-fold), permeability coefficients (seven-fold), and retentions (two-fold) of both PCl and LCl through the epithelium, regardless of the concentration. Moreover, the resistance and flexibility of the films markedly decreased compared to those without α-bisabolol. Therefore, under the experimental conditions, using α-bisabolol as a buccal permeation enhancer for the hydrophilic local anesthetics PCl and LCl from buccal films is not feasible.


  • Open Access

    Metronidazole Modified-Release Therapy Using Two Different Polymeric Systems Gels or Films: Clinical Study for the Treatment of Periodontitis

    by Mônica Danielle Ribeiro Bastos, Tatiane Cristina Dotta, Beatriz Roque Kubata, Cássio Do Nascimento, Ana Paula Macedo, Fellipe Augusto Tocchini de Figueiredo, Millena Mangueira Rocha, Maria Paula Garofo Peixoto, Maíra Peres Ferreira, Osvaldo de Freitas, et al.

    This study evaluated the efficacy of semisolid systems (gels) and films containing a combination of metronidazole (MTZ) and metronidazole benzoate after scaling and root-planing (SRP) for periodontitis. In total, 45 patients with stage I or II periodontitis were enrolled and divided into 3 groups: 1—SRP—control; 2—SRP + Film with MTZ; 3—SRP + Gel with MTZ. The pH of gingival crevicular fluid (GCF) before/after treatments, MTZ concentrations, and drug release using high-performance liquid chromatography were investigated. The effects were evaluated by longitudinal monitoring of clinical parameters (probing depth—PD, clinical attachment level—CAL, and bleeding on probing—BP). MTZ and MTZ-benzoate concentrations in the periodontal pocket and pH showed no statistical difference after application. SRP + Gel presented the lowest CAL values. For SRP + Film and SRP + Gel, higher PD values were observed at T0 compared to all groups. A relevant reduction in BP was observed in SRP + Film and SRP + Gel groups at all times compared to T0. Both therapies improved periodontal health compared to SRP alone, reducing PD and BP, and increasing CAL for the gel group, suggesting they are promising for periodontal disease treatment.


  • Open Access

    The Potential of Films as Transmucosal Drug Delivery Systems

    by Ana Clara Wada de Carvalho, Natália Floriano Paiva, Isabella Kriunas Demonari, Maíra Peres Ferreira Duarte, Renê Oliveira Do Couto, Osvaldo de Freitas, Fabiana Testa Moura de Carvalho Vicentini

    Pharmaceutical films are polymeric formulations used as a delivery platform for administration of small and macromolecular drugs for local or systemic action. They can be produced by using synthetic, semi-synthetic, or natural polymers through solvent casting, electrospinning, hot-melt extrusion, and 3D printing methods, and depending on the components and the manufacturing methods used, the films allow the modulation of drug release. Moreover, they have advantages that have drawn interest in the development and evaluation of film application on the buccal, nasal, vaginal, and ocular mucosa. This review aims to provide an overview of and critically discuss the use of films as transmucosal drug delivery systems. For this, aspects such as the composition of these formulations, the theories of mucoadhesion, and the methods of production were deeply considered, and an analysis of the main transmucosal pathways for which there are examples of developed films was conducted. All of this allowed us to point out the most relevant characteristics and opportunities that deserve to be taken into account in the use of films as transmucosal drug delivery systems.


  • Open Access

    Preemptive analgesia with ibuprofen increases anesthetic efficacy in children with severe molar: a triple-blind randomized clinical trial

    by Fernanda Vicioni-Marques, Francisco Wanderley Garcia de Paula-Silva, Milena Rodrigues Carvalho, Alexandra Mussolino de Queiroz, Osvaldo de Freitas, Maíra Peres Ferreira Duarte, David John Manton, Fabrício Kitazono de Carvalho

    This study evaluated the effectiveness of preemptive analgesia in children with severe MIH, post-eruptive enamel breakdown, and hypersensitivity. Ibuprofen (10 mg/kg child weight) or placebo was administered, followed by infiltrative anesthesia and restoration with resin composite. Hypersensitivity was evaluated in five moments. The data were analyzed using the chi-square test, Fisher’s exact test, and t-test. Preemptive analgesia provided benefits for the treatment of severe cases of MIH, with an increase in the effectiveness of infiltrative anesthesia and improved patient comfort during the restorative procedure. Preemptive analgesia has shown efficacy in reducing hypersensitivity during restorative dental procedures, evidencing the significance of this study for patients with MIH and hypersensitivity.


  • Herpes Labialis: A New Possibility for Topical Treatment with Well-Elucidated Drugs

    by Amanda F. Silva-Alvarez, Ana Clara Wada de Carvalho, Érica Benassi-Zanqueta, Thalita Z. Oliveira, Dyenefer P. Fonseca, Maíra P. Ferreira, Fabiana T.M.C. Vicentini, Tania Ueda-Nakamura, Vinicius Pedrazzi, Osvaldo de Freitas


  • Open Access

    O efeito da divisão na qualidade e na liberação in vitro de cloridrato de metformina de comprimidos de liberação prolongada (XR)

    by Luiz Gustavo da Fonseca Santos, Adriana Inés Segall, Yong Ki Han, Maria Patricia Kizelman, Maíra Peres Ferreira, Amanda Cristina Funari Silva, Frederico Severino Martins, Whocely Victor de Castro, Osvaldo de Freitas, Renê Oliveira Do Couto

    O cloridrato de metformina (MetCl) é usado mundialmente no tratamento do diabetes mellitus tipo 2. Embora os comprimidos de liberação prolongada (XR) contendo 500 mg, 850 mg e 1000 mg de MetCl sejam comercializados, não é incomum dividir o comprimido quando a dosagem necessária não está disponível comercialmente. O objetivo do trabalho foi avaliar os efeitos da divisão no desempenho in vitro de comprimidos XR contendo MetCl. Realizamos ensaios de controle de qualidade e estudos de perfil de dissolução comparativos entre diversos medicamentos contendo 500 mg e 1000 mg de MetCl, comercializados no Brasil e na Argentina. Comprimidos contendo 1000 mg de MetCl foram divididos pela metade (amostras de teste) e comparados com comprimidos inteiros de produtos contendo 500 mg de MetCl (amostras de referência). Os comprimidos reduzidos ao meio são mais frágeis e apresentam menor uniformidade de massa e unidade de dosagem em relação aos inteiros. No entanto, foi evidenciado pelo parâmetro de F2 bootstrapping que a divisão dos comprimidos de MetCl XR não afetou significativamente os perfis de liberação do fármaco in vitro em comparação com os comprimidos inteiros. Além disso, nem o mecanismo de liberação do fármaco nem a cinética de liberação foram significativamente afetados. Os comprimidos XR contendo 1000 mg de cloridrato de metformina podem ser elegíveis para divisão, no entanto, os fabricantes devem fornecer sulcos adequadas nas superfícies dos comprimidos para tornar a divisão adequada e mais segura para os pacientes.